Metaxalone Tablet
Product Images NDC 68788-7675

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metaxalone (NDC 68788-7675). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Metaxalone Tablets 1)

Chemical structure of Metaxalone showing its molecular configuration with methyl groups attached to a benzene ring and a carbamate functional group.*

FDA Label Image

Figure 1 (Metaxalone Tablets 2)

A line graph showing mean concentrations (ng/mL) of Metaxalone over 12 hours after an 800 mg oral dose, comparing fasted and fed conditions. Concentration peaks higher and later under fed conditions, with standard deviation error bars indicated for each time point.*

FDA Label Image

Metaxalone Tablets 800mg (Metaxalone Tablets 3)

Label for Metaxalone Tablets 800 mg oral tablets, generic for Skelaxin, manufactured by Lannett Co. Inc., Philadelphia, PA, and distributed by Preferred Pharmaceuticals, Inc. The label includes dosing instructions in English and Spanish advising not to drink alcohol while taking the medication and to take specified tablet quantities at directed intervals. It also contains storage instructions and a federal law caution about drug transfer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.